Healthcare data firm SK&A sold to Cegedim

US— Healthcare data and research firm SK&A has been sold to Cegedim Dendrite, a CRM services business focused on the life sciences industry.

SK&A holds contact and profiling information on more than two million healthcare practitioners, which Cegedim plans to use to bolster its OneKey database services in the US.

Dave Escalante, SK&A’s president and CEO, will continue to lead the business in his new role of vice president of data and information solutions.

Cegedim Dendrite is part of the Cegedim Group, which has headquarters in France. Previous acquisitions include patient data firm Hospital Marketing Services and pharma intelligence firm Nomi.

We hope you enjoyed this article.
Research Live is published by MRS.

The Market Research Society (MRS) exists to promote and protect the research sector, showcasing how research delivers impact for businesses and government.

Members of MRS enjoy many benefits including tailoured policy guidance, discounts on training and conferences, and access to member-only content.

For example, there's an archive of winning case studies from over a decade of MRS Awards.

Find out more about the benefits of joining MRS here.

1 Comment

Ishwar

I believe that Cegedim could be a major contender as a data vendor, but I feel that general information like prescriber information should be readily available to pharma companies via a congregated effort by them which would bring doen their data acquisition costs significantly.

Like Report

Display name

Email

Join the discussion


Display name

Email

Join the discussion

Newsletter
Stay connected with the latest insights and trends...
Sign Up
Latest From MRS

Our latest training courses

Our new 2025 training programme is now launched as part of the development offered within the MRS Global Insight Academy

See all training

Specialist conferences

Our one-day conferences cover topics including CX and UX, Semiotics, B2B, Finance, AI and Leaders' Forums.

See all conferences

MRS reports on AI

MRS has published a three-part series on how generative AI is impacting the research sector, including synthetic respondents and challenges to adoption.

See the reports

Progress faster...
with MRS 
membership

Mentoring

CPD/recognition

Webinars

Codeline

Discounts